# FDA recall D-0488-2015

> **Actavis Laboratories, FL, Inc.** · Class III · drug recall initiated 2015-03-26.

## Product

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

## Reason for recall

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0488-2015
- **Recalling firm:** Actavis Laboratories, FL, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-03-26
- **Report date:** 2015-04-22
- **Termination date:** 2016-12-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Davie, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0488-2015

## Citation

> AI Analytics. FDA recall D-0488-2015. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0488-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*